Virtu Financial LLC Mesoblast LTD Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.22 - $4.83 $75,715 - $299,759	62,062 New	62,062 $76,000
Q2 2022 Aug 09, 2022	BUY	$2.22 - $4.54 $3,005 - $6,147	1,354 Added 12.37%	12,301 $27,000
Q1 2022 May 17, 2022	SELL	$3.58 - $4.98 $120,760 - $167,985	-33,732 Reduced 75.5%	10,947 $46,000
Q4 2021 Feb 17, 2022	BUY	$4.17 - $7.09 $186,311 - $316,774	44,679 New	44,679 $214,000
Q3 2021 Nov 12, 2021	SELL	$5.87 - $7.85 $101,674 - $135,969	-17,321 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$6.69 - $9.0 $31,964 - $43,002	4,778 Added 38.09%	17,321 $130,000
Q1 2021 May 19, 2021	SELL	$8.26 - $11.4 $178,886 - $246,889	-21,657 Reduced 63.32%	12,543 $104,000
Q4 2020 Feb 24, 2021	BUY	$8.21 - $18.59 $57,355 - $129,869	6,986 Added 25.67%	34,200 $290,000
Q1 2018 May 14, 2018	BUY	$4.91 - $7.72 $133,620 - $210,092	27,214 New	27,214 $157,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.